Strepsils Intensive spray d / mestn. apply. dosage 8.75mg / dose vial 15ml
Category
Sore throat
Scope of the medicinal product
Ear, Throat, Nose
Release form
Spray
Manufacturer country
Thailand
Package quantity, pcs
one
Structure
1 dose (3 sprays) contains flurbiprofen 8.75 mg
Excipients: Betadex 22.83 mg
sodium hydrogen phosphate dodecahydrate 17.19 mg
citric acid monohydrate 0.63 mg, methyl parahydroxybenzoate 1.18 mg
propyl parahydroxybenzoate 0.24mg
sodium hydroxide 1.30 mg
Mint Flavor (PHL 175628) 1.08 mg
cherry flavor (PHL 175629) 1.35 mg
N-2,3-trimethyl-2-isopropylbutanamide 0.54mg
sodium saccharin 0.27 mg
hydroxypropylbetadex 12.09 mg
water 492.55 mg.
pharmachologic effect
Non-steroidal anti-inflammatory drug
Indications
As a symptomatic agent for the relief of sore throat in infectious and inflammatory diseases of the upper respiratory tract
Application during pregnancy and lactation
The use of the drug in the third trimester of pregnancy is contraindicated.
Avoid the use of flurbiprofen in the I and II trimesters of pregnancy, if necessary, the use of the drug, you should consult your doctor.
There is evidence that small amounts of flurbiprofen can pass into breast milk without any negative consequences for the health of an infant, however, due to the possible side effects of NSAIDs, the use of the drug during breastfeeding is not recommended.
Contraindications
Hypersensitivity to flurbiprofen or to any of the other components of the drug.
a history of hypersensitivity reactions (bronchial asthma, bronchospasm, rhinitis, Quincke's edema, urticaria, recurrent polyposis of the nose or paranasal sinuses) in response to the use of acetylsalicylic acid or other NSAIDs
erosive and ulcerative diseases of the gastrointestinal tract (including peptic ulcer of the stomach and duodenum), ulcerative bleeding in phase or in history (2 or more confirmed episodes of peptic ulcer or ulcerative bleeding):
bleeding or perforation of the gastrointestinal tract ulcer, ulcerative colitis, hemorrhagic and hematopoietic disorders in the history, provoked by the use of NSAIDs
pregnancy (III trimester)
period of breastfeeding
children under 12 years old
severe liver failure or active liver disease
renal failure of severe severity (CC < 30 ml / min)
decompensated heart failure
the period after coronary artery bypass grafting
confirmed hyperkalemia
deficiency of glucose-6-phosphate dehydrogenase
hemophilia and other blood clotting disorders (including hypocoagulation), hemorrhagic diathesis.
With caution and only after consulting a doctor, you should take the drug if you have a history of a single episode of gastric ulcer or ulcerative bleeding of the gastrointestinal tract a history of gastrointestinal diseases (ulcerative colitis, Crohn's disease), gastritis, enteritis, colitis, the presence of Helicobacter pylori infection bronchial asthma or allergic diseases in the stage of exacerbation or in history (development of bronchospasm is possible) systemic lupus erythematosus or mixed connective tissue disease (Sharp's syndrome), because increased risk of aseptic meningitis (with short-term use of flurbiprofen, the risk is negligible) renal failure, incl. with dehydration (CC less than 30-60 ml / min), nephrotic syndrome liver failure liver cirrhosis with portal hypertension hyperbilirubinemia arterial hypertension and / or heart failure, edema concomitant use of other NSAIDs the simultaneous use of drugs that can increase the risk of ulcers or bleeding, in particular GCS for oral administration (including prednisolone), anticoagulants (including warfarin), antiplatelet agents (including acetylsalicylic acid, clopidogrel ), selective serotonin reuptake inhibitors (including citalopram, fluoxetine, paroxetine, sertraline) in the I and II trimesters of pregnancy, during breastfeeding patientacetylsalicylic acid, clopidogrel), selective serotonin reuptake inhibitors (including citalopram, fluoxetine, paroxetine, sertraline) in the I and II trimesters of pregnancy, during breastfeeding patientacetylsalicylic acid, clopidogrel), selective serotonin reuptake inhibitors (including citalopram, fluoxetine, paroxetine, sertraline) in the I and II trimesters of pregnancy, during breastfeeding patient
Name ENG
STREPSILS INTENSIV
Clinical and pharmacological group
Drug with antimicrobial and local anesthetic action for local use in ENT practice and dentistry
ATX code
Flurbiprofen
Dosage
8.75mg / dose x 15ml
Structure
dose (3 sprays) contains flurbiprofen 8.75 mg Excipients: Betadex 22.83 mg
sodium hydrogen phosphate dodecahydrate 17.19 mg
citric acid monohydrate 0.63 mg, methyl parahydroxybenzoate 1.18 mg
propyl parahydroxybenzoate 0.24mg
sodium hydroxide 1.30 mg
Mint Flavor (PHL 175628) 1.08 mg
cherry flavor (PHL 175629) 1.35 mg
N-2,3-trimethyl-2-isopropylbutanamide 0.54mg
sodium saccharin 0.27 mg
hydroxypropylbetadex 12.09 mg
water 492.55 mg.
INN / Active ingredient
Flurbiprofen
Storage conditions and periods
At a temperature not exceeding 30 degrees (do not store in the refrigerator, do not freeze).
Expiration date: 2 years
after opening - 6 months
Specifications
Category
Sore throat
Scope of the medicinal product
Ear, Throat, Nose
Release form
Spray
Manufacturer country
Thailand
Package quantity, pcs
one
Minimum age from
12 years
Way of introduction
Through the respiratory tract
Vacation conditions
Without recipe
Volume, ml.
15 ml
Brand name
Reckitt benckiser
The amount of the dosage form in the primary package
15 ml
Primary packaging type
Bottle
Type of consumer packaging
Pack of cardboard
Pharmaco-therapeutic group
Non-steroidal anti-inflammatory drug
Anatomical and therapeutic characteristics
R02AX01 Flurbiprofen
Dosage form
Dosed topical spray
The target audience
Children
Dosage (volume) of the substance in the preparation
flurbiprofen 8.75 mg
Expiration date in days
730
Package weight, g
5
Mode of application
:
Read the instructions carefully before using the drug.
For topical use.
For short term use only.
Adults and children over 12 years old: spray 1 dose of the drug (3 pressings on the dispenser) along the back wall of the oropharynx every 3-6 hours, no more than 5 doses within 24 hours.
Duration of therapy: no more than 3 days.
Do not inhale when spraying.
Before the first use of the drug, it is necessary to make at least four clicks on the dispenser in the opposite direction until a uniform spray appears.
Before each subsequent use, it is necessary to make at least one press on the dispenser in the opposite direction from you until a uniform spray appears.
Information on technical characteristics, delivery set, country of manufacture